NCT07008365View on ClinicalTrials.gov

The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure

PHASE3RecruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Heart FailureCongestive Heart FailureIntraabdominal HypertensionCardio-Renal Syndrome
Interventions
DRUG

Furosemide 20 Milligrams

Decongestive therapy with e.v. furosemide +/- hydrochlorothiazide will be adjusted by intraabdominal pressure and/or point of care ultrasound

Trial Locations (2)

50008

RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza

50009

NOT_YET_RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza

All Listed Sponsors
lead

Instituto de Investigación Sanitaria Aragón

OTHER